Our objective is to prepare monoclonal antibodies that recognize the antigens expressed by acute nonlymphocytic leukemic (ANL) colony-forming cells. We will then use these antibodies to separate malignant progenitor cells from those capable of normal hematopoiesis. Success in these studies may lead to the development of new methods of treating ANL. Our approach is based on our previous development of monoclonal antibodies that recognize normal myeloid stem cells and their progeny at distinct stages of differentiation. These monoclonal antibodies were able to deplete leukemic colony-forming cells from patients with ANL without completely eliminating normal stem cells. An important aspect of these studies was the use of a clonal marker to discern the malignant versus normal origin of the separated stem cell populations. In the period of this research we will: (1) produce monoclonal antibodies capable of lysing malignant colony-forming cells; (2) examine the cellular and biochemical specificity of these antibodies; (3) determine the antigenic phenotype and differentiative capacity of the malignant colony-forming cells; and (4) use these antibodies to lyse colony-forming cells present in ANL specimens that express a clonal marker. Under these conditions we can test whether the colony-forming cells remaining after lysis are predominantly derived from the leukemic clone or are of nonclonal, presumably normal, origin. This selective depletion of ANL progenitor cells would provide a rational basis for monoclonal antibody treatment of ANL. (MI)

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA039492-03
Application #
3178533
Study Section
Experimental Immunology Study Section (EI)
Project Start
1985-08-01
Project End
1988-07-31
Budget Start
1987-08-01
Budget End
1988-07-31
Support Year
3
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Behm, F G; Smith, F O; Raimondi, S C et al. (1996) Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. Blood 87:1134-9
Smith, F O; Rauch, C; Williams, D E et al. (1996) The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q Blood 87:1123-33
Smith, F O; Raskind, W H; Fialkow, P J et al. (1995) Cellular biology of acute myelogenous leukemia. J Pediatr Hematol Oncol 17:113-22
Park, J R; Bernstein, I D; Hockenbery, D M (1995) Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood 86:868-76
Bigas, A; Martin, D I; Bernstein, I D (1995) Generation of hematopoietic colony-forming cells from embryonic stem cells: synergy between a soluble factor from NIH-3T3 cells and hematopoietic growth factors. Blood 85:3127-33
Milner, L A; Kopan, R; Martin, D I et al. (1994) A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood 83:2057-62
Ekert, H; Sievers, E L; Tan, A et al. (1994) GATA-1 is expressed in acute erythroblastic leukaemia. Br J Haematol 86:410-2
Smith, F O; Raskind, W H; Waldron, P et al. (1993) Clonal remission in childhood acute myeloid leukemia is an infrequent event. Leukemia 7:929-32
Brashem-Stein, C; Flowers, D A; Smith, F O et al. (1993) Ontogeny of hematopoietic stem cell development: reciprocal expression of CD33 and a novel molecule by maturing myeloid and erythroid progenitors. Blood 82:792-9
Rowley, S D; Brashem-Stein, C; Andrews, R et al. (1993) Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity. Blood 82:60-5

Showing the most recent 10 out of 29 publications